Keyser Jane Elizabeth 4

What Happened

• Jane Elizabeth Keyser, an independent director of Neuraxis, Inc. (NRXS), was issued 21,598 shares of common stock as an award/compensation on January 22, 2026. The shares were valued at $4.63 each, for a total value of $99,999. This was a grant/award of stock (transaction code A), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-01-22; price per share: $4.63; total value: $99,999.
• Shares owned after transaction: Not specified in the filing.
• Footnote: Shares were issued as compensation for services as an independent director (Footnote F1).
• Filing date: 2026-02-26 — the Form 4 was filed 35 days after the transaction, which is later than the typical two-business-day reporting window, reducing near‑term transparency.

Context

• This was an equity grant as director compensation, a common practice to align board members with shareholder interests; it is not a market purchase or sale and should not be read as an immediate buy/sell signal.
• Because this was an award (not an exercise or sale), there is no cash change for the reporting person at grant time and no immediate tax‑withholding sale noted.